Sacha Gnjatic Selected Research

Vaccines

2/2023	Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission.
2/2023	Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy.
6/2022	Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy.
1/2022	Shift of lung macrophage composition is associated with COVID-19 disease severity and recovery.
1/2022	A shift in lung macrophage composition is associated with COVID-19 severity and recovery.
1/2022	Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity.
1/2022	Cancer vaccines.
7/2021	Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies.
11/2020	A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1.
1/2020	Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sacha Gnjatic Research Topics

Disease

125	Neoplasms (Cancer) 12/2023 - 08/2002
56	Testicular Neoplasms (Testicular Cancer) 07/2021 - 12/2002
30	Melanoma (Melanoma, Malignant) 01/2021 - 12/2006
22	COVID-19 06/2023 - 05/2020
14	Ovarian Neoplasms (Ovarian Cancer) 02/2023 - 09/2003
11	Ovarian Epithelial Carcinoma 01/2016 - 09/2003
10	Multiple Myeloma 04/2024 - 02/2007
9	Inflammation (Inflammations) 01/2024 - 04/2016
8	Disease Progression 02/2023 - 01/2013
6	Lung Neoplasms (Lung Cancer) 01/2024 - 03/2004
6	Neoplasm Metastasis (Metastasis) 11/2023 - 09/2011
5	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 12/2003
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 03/2004
4	Breast Neoplasms (Breast Cancer) 01/2024 - 03/2004
3	Leukemia 01/2023 - 03/2012
3	Infections 01/2023 - 07/2020
3	Fatigue 01/2022 - 12/2012
3	Crohn Disease (Crohn's Disease) 01/2022 - 10/2016
3	Hypoxia (Hypoxemia) 10/2020 - 01/2017
3	Lymphoma (Lymphomas) 01/2019 - 02/2006
3	Synovial Sarcoma (Synovioma) 10/2017 - 01/2006
3	Prostatic Neoplasms (Prostate Cancer) 11/2013 - 07/2003
3	Esophageal Neoplasms (Esophageal Cancer) 04/2013 - 10/2004
3	Hypersensitivity (Allergy) 01/2013 - 07/2004
3	Fowlpox 04/2012 - 07/2003
3	Colorectal Neoplasms (Colorectal Cancer) 09/2011 - 09/2006
2	Multiple Sclerosis 02/2023 - 06/2022
2	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 02/2008
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 02/2008
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2004
2	Tetanus 01/2021 - 01/2012
2	Agammaglobulinemia (Hypogammaglobulinemia) 06/2020 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017 - 03/2010
2	Communicable Diseases (Infectious Diseases) 11/2017 - 12/2011
2	Lymphatic Metastasis 02/2017 - 07/2003
2	Esophageal Squamous Cell Carcinoma 01/2016 - 10/2004
2	Injection Site Reaction 12/2012 - 11/2008
2	Vaccinia 04/2012 - 09/2006
1	Small Cell Carcinoma 04/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024

Drug/Important Bio-Agent (IBA)

89	AntigensIBA 01/2023 - 08/2002
40	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2002
37	VaccinesIBA 02/2023 - 09/2002
25	Peptides (Polypeptides)IBA 01/2021 - 08/2002
23	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2009
21	CytokinesIBA 12/2023 - 06/2008
20	Neoplasm Antigens (Tumor Antigens)IBA 07/2020 - 03/2004
16	AntibodiesIBA 01/2022 - 08/2002
14	EpitopesIBA 10/2022 - 09/2002
13	IpilimumabIBA 01/2024 - 12/2008
11	Messenger RNA (mRNA)IBA 01/2022 - 07/2003
9	RNA (Ribonucleic Acid)IBA 12/2023 - 07/2010
9	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2018
9	Interleukin-6 (Interleukin 6)IBA 01/2023 - 04/2010
9	Monoclonal AntibodiesIBA 01/2021 - 12/2008
9	Cancer VaccinesIBA 04/2012 - 03/2004
7	AutoantibodiesIBA 01/2023 - 01/2009
5	Monatide (IMS 3015)IBA 02/2023 - 05/2008
5	Interleukin-8 (Interleukin 8)IBA 08/2022 - 05/2020
5	Recombinant ProteinsIBA 11/2020 - 03/2004
4	NivolumabIBA 01/2024 - 02/2023
4	Gemcitabine FDA Link 01/2024 - 01/2018
4	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 01/2018
4	Protein Subunit VaccinesIBA 02/2023 - 12/2002
4	Immunoglobulin G (IgG)IBA 01/2022 - 03/2010
4	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 09/2002
3	Blood Proteins (Serum Proteins)IBA 06/2023 - 08/2022
3	COVID-19 VaccinesIBA 01/2022 - 01/2021
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022 - 11/2008
3	poly ICLCIBA 01/2020 - 12/2012
3	EnzymesIBA 10/2013 - 03/2004
3	HLA-A2 Antigen (HLA A2 Antigen)IBA 11/2007 - 09/2002
2	HLA Antigens (Human Leukocyte Antigens)IBA 02/2023 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2014
2	Small Cytoplasmic RNAIBA 10/2022 - 01/2021
2	fibrin fragment D (D-dimer)IBA 06/2020 - 01/2020
2	Ferritins (Ferritin)IBA 06/2020 - 01/2020
2	ParaffinIBA 01/2019 - 12/2003
2	Immunologic Adjuvants (Immunologic Adjuvant)IBA 03/2015 - 11/2008
2	HLA-DPB1 antigen (HLA DPB1)IBA 04/2014 - 11/2004
2	AutoantigensIBA 12/2012 - 02/2009
2	CTLA-4 AntigenIBA 10/2011 - 12/2008
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2010 - 07/2007
2	ProteomeIBA 03/2010 - 02/2009
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 08/2008 - 12/2003
1	Lenalidomide (CC 5013)FDA Link 04/2024
1	elotuzumabIBA 04/2024
1	Interleukin-4 (Interleukin 4)IBA 12/2023
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 10/2023

Therapy/Procedure

51	Immunotherapy 01/2024 - 09/2002
30	Therapeutics 04/2024 - 02/2009
7	Drug Therapy (Chemotherapy) 01/2023 - 02/2007
3	Stem Cell Transplantation 04/2024 - 02/2007
3	Radiotherapy 12/2018 - 03/2012
2	Organ Sparing Treatments 01/2024 - 11/2023
2	Cystectomy 11/2023 - 12/2003
2	Immunomodulation 02/2023 - 06/2022
2	Hematopoietic Stem Cell Transplantation 01/2023 - 06/2014
2	Injections 04/2016 - 03/2015